Gerasimos Filippatos

Sep 3, 2024 | onlinelibrary.wiley.com | Gerasimos Filippatos |Stefan Anker |George Bakris |Peter Rossing

Introduction Cardiovascular disease (CVD) and its related morbidity and mortality is associated with left ventricular hypertrophy (LVH).1-3 Hypertension is common in patients with chronic kidney disease (CKD) and type 2 diabetes (T2D); patients with these co-morbidities have a high prevalence of left ventricular (LV) hypertrophy.1-3 Finerenone is a selective, nonsteroidal mineralocorticoid receptor antagonist (MRA).

Jul 1, 2024 | jacc.org | Milton Packer |Joao Ferreira |Javed Butler |Gerasimos Filippatos

IntroductionSodium-glucose cotransporter 2 (SGLT2) inhibitors reduce the risk of cardiovascular death and hospitalization for heart failure in patients with heart failure, both with reduced and preserved ejection fraction.1 Potential mechanisms of action have been elucidated in both experimental models and in the clinical setting.

Apr 1, 2024 | dom-pubs.onlinelibrary.wiley.com | Khawaja M Talha |Jennifer Green |Gerasimos Filippatos |Stuart J. Pocock

CONFLICT OF INTEREST STATEMENT KMT has no conflicts of interest to declare. JG reports personal fees from Boehringer Ingelheim, Lilly, Bayer, Novo Nordisk, Pfizer, AstraZeneca, Sanofi, Hawthorne Effect, Omada Health, Vertex Pharmaceuticals, Valo Therapeutics and Anji Pharmaceuticals; receiving grants from Merck, Roche, Sanofi and Lexicon Pharmaceuticals.

Feb 12, 2024 | jamanetwork.com | Javed Butler |Baylor Scott |Muhammad Usman |Gerasimos Filippatos

Key PointsQuestion  What are the safety and efficacy of empagliflozin in patients with heart failure and preserved ejection fraction (HFpEF) with background diuretic use?

Nov 23, 2023 | futuremedicine.com | Javed Butler |Gerasimos Filippatos

This is an abstract of the Plain Language Summary of Publication article. To read the full Plain Language Summary of this article, click here to view the PDF. Link to original article hereAcknowledgmentsThe authors and the study sponsors thank all the people who participated in the study.